Novartis Ag (NVS) Income from Continuing Operations (2009 - 2025)

Novartis Ag (NVS) has 15 years of Income from Continuing Operations data on file, last reported at 5038000000.0 in Q2 2025.

• Quarterly Income from Continuing Operations rose 13.57% year-over-year to 5038000000.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was 21842000000.0 (down 99.56% YoY) and the FY2025 annual result came in at 13967000000.0, up 16.99% from the prior year.
• Income from Continuing Operations retreated to 5038000000.0 in Q2 2025 per NVS's latest filing, from 7435000000.0 in the prior quarter.
• The five-year high for Income from Continuing Operations was 34001372000000.0 in Q1 2022, with the low at 1323000000.0 in Q1 2021.
• Average Income from Continuing Operations over 5 years is 2860682214285.71, with a median of 4949000000.0 recorded in 2022.
• Year-over-year, Income from Continuing Operations surged 2569920.56% in 2022 and sank 85.29% in 2023.
• Novartis Ag's Income from Continuing Operations stood at 6601000000.0 in 2021, then declined by 24.78% to 4965000000.0 in 2022, then fell by 0.64% to 4933000000.0 in 2023, then surged by 50.72% to 7435000000.0 in 2024, then tumbled by 32.24% to 5038000000.0 in 2025.
• Business Quant data shows NVS's Income from Continuing Operations at 5038000000.0 in Q2 2025, 7435000000.0 in Q4 2024, and 4436000000.0 in Q2 2024.